Select a medication above to begin.
Tividenofusp Alfa
tividenofusp alfa
Adult Dosing .
Dosage forms: INJ
Investigational New Drug (IND)
- [pending FDA approval]
mucopolysaccharidosis II
- [indication/patient population pending FDA approval]
- Info: delivers deficient iduronate-2-sulfatase enzyme to body and brain, reducing lysosomal glycosaminoglycans accumulation
Peds Dosing .
- Dosage forms: INJ
Investigational New Drug (IND)
- [pending FDA approval]
mucopolysaccharidosis II
- [indication/patient population pending FDA approval]
- Info: delivers deficient iduronate-2-sulfatase enzyme to body and brain, reducing lysosomal glycosaminoglycans accumulation